Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Search
Filing date Form Description View
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-19-004062.pdf
0001179110-19-004062.rtf
8-K

Report of unscheduled material events or corporate event

 View HTML
0001104659-19-017829.pdf
0001104659-19-017829.rtf
0001104659-19-017829.xls
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

 View HTML
0001047469-19-001686.pdf
0001047469-19-001686.rtf
0001047469-19-001686.xls
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

 View HTML
0001047469-19-001772.pdf
0001047469-19-001772.rtf
0001047469-19-001772.xls
8-K

Report of unscheduled material events or corporate event

 View HTML
0001104659-19-018709.pdf
0001104659-19-018709.rtf
0001104659-19-018709.xls
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

 View HTML
0001558370-19-003477.pdf
0001558370-19-003477.rtf
0001558370-19-003477.xls
DEFA14A

Additional proxy soliciting materials - definitive

 View HTML
0001558370-19-003479.pdf
0001558370-19-003479.rtf
0001558370-19-003479.xls
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-19-004566.pdf
0001558370-19-004566.rtf
0001558370-19-004566.xls
10-Q

Quarterly report which provides a continuing view of a company's financial position

 View HTML
0001558370-19-004709.pdf
0001558370-19-004709.rtf
0001558370-19-004709.xls
EX-101.INS - EX-101.INS
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-19-005447.pdf
0001558370-19-005447.rtf
0001558370-19-005447.xls